Posted by Michael Wonder on 27 Jan 2017
Post-market review of ezetimibe – draft report
27 January 2017 - Public consultation on the draft Report to the PBAC of the post-market review of ezetimibe is now open.
Interested organisations and individuals are invited to provide a submission addressing the draft report.
The public submission process will be open for 2 weeks and will close at 5 pm Friday, 10 February 2017.
